Innovation
1 December 2024Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.
2 December 202111.3 min readMuch of our research has the potential to positively impact people's lives around the world. And who better to deliver this than the scientists themselves?
28 April 20209.8 min readThis World Malaria Day we look at three ambitious projects, backed by the Sanger Institute Technology Transfer Office, which are tackling areas key to eliminating malaria.
11 February 20197.6 min readGary Dillon, Business Development Manager at the Sanger Institute gives us his view on some of the powers and pitfalls of genomics.
22 June 20153 min read22.06.15 Artificial membrane could transform the way we treat heart disease, says Rameen Shakur
18 March 20155.2 min read18.03.15 Some scientific discoveries become life-changing technologies while others never make it to the clinic. Sarion Bowers introduces an initiative aimed at ensuring progress benefits patients
19 July 20122.8 min read19 Jul 2012: Institute researchers and administrators met with Vicky Ford MEP to influence the shape of future EU funding of research projects
